8.14
price up icon5.99%   0.46
 
loading
Schlusskurs vom Vortag:
$7.68
Offen:
$7.76
24-Stunden-Volumen:
87,955
Relative Volume:
1.04
Marktkapitalisierung:
$259.22M
Einnahmen:
$193.67M
Nettoeinkommen (Verlust:
$4.82M
KGV:
58.02
EPS:
0.1403
Netto-Cashflow:
$15.53M
1W Leistung:
+6.27%
1M Leistung:
-1.33%
6M Leistung:
-19.41%
1J Leistung:
-20.35%
1-Tages-Spanne:
Value
$7.75
$8.17
1-Wochen-Bereich:
Value
$7.57
$8.17
52-Wochen-Spanne:
Value
$7.15
$13.77

Zynex Inc Stock (ZYXI) Company Profile

Name
Firmenname
Zynex Inc
Name
Telefon
(800)-495-6670
Name
Adresse
9655 MAROON CIRCLE, ENGLEWOOD, CO
Name
Mitarbeiter
1,101
Name
Twitter
@zynexmedical
Name
Nächster Verdiensttermin
2024-10-24
Name
Neueste SEC-Einreichungen
Name
ZYXI's Discussions on Twitter

Vergleichen Sie ZYXI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
9.30 0 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.2299 485.17M 2.07B -1.42B -1.37B -0.6765
 icon
GOODO
Gladstone Commercial Corporation
21.16 372.90M 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
0.3236 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
2.40 103.35M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
3.72 48.39M 0 0 0 0.00

Zynex Inc Stock (ZYXI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-10-16 Eingeleitet RBC Capital Mkts Outperform
2023-01-06 Hochstufung Piper Sandler Neutral → Overweight
2022-02-28 Bestätigt B. Riley Securities Buy
2021-07-16 Hochstufung B. Riley Securities Neutral → Buy
2021-03-09 Hochstufung Northland Capital Market Perform → Outperform
2021-02-26 Herabstufung B. Riley Securities Buy → Neutral
2021-01-29 Herabstufung Piper Sandler Overweight → Neutral
2021-01-28 Herabstufung Northland Capital Outperform → Market Perform
2020-09-14 Hochstufung H.C. Wainwright Neutral → Buy
2020-09-09 Hochstufung Northland Capital Market Perform → Outperform
2020-07-29 Hochstufung B. Riley FBR Neutral → Buy
2020-07-20 Eingeleitet Piper Sandler Overweight
2020-07-13 Herabstufung B. Riley FBR Buy → Neutral
2020-07-10 Bestätigt H.C. Wainwright Neutral
2020-06-16 Herabstufung Northland Capital Outperform → Market Perform
2020-05-19 Herabstufung H.C. Wainwright Buy → Neutral
2020-04-01 Eingeleitet Northland Capital Outperform
2019-09-23 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Zynex Inc Aktie (ZYXI) Neueste Nachrichten

pulisher
Jan 21, 2025

Barclays PLC Has $236,000 Holdings in Zynex, Inc. (NASDAQ:ZYXI) - Defense World

Jan 21, 2025
pulisher
Jan 17, 2025

Electrotherapy System Market Growth in Future Scope 2025-2032 | - openPR

Jan 17, 2025
pulisher
Jan 13, 2025

Jane Street Group LLC Acquires 1,929 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World

Jan 13, 2025
pulisher
Jan 08, 2025

(ZYXI) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Jan 08, 2025
pulisher
Jan 07, 2025

Zynex to Present at the H.C. Wainwright Global Investment Conference - GuruFocus.com

Jan 07, 2025
pulisher
Jan 07, 2025

Geode Capital Management LLC Has $3.47 Million Position in Zynex, Inc. (NASDAQ:ZYXI) - Defense World

Jan 07, 2025
pulisher
Jan 07, 2025

Muscle Stimulation Devices Market Overall Study Report - openPR

Jan 07, 2025
pulisher
Jan 06, 2025

Barclays PLC Acquires 8,713 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World

Jan 06, 2025
pulisher
Jan 06, 2025

Electrotherapy System Market Detailed In New Research Report - openPR

Jan 06, 2025
pulisher
Jan 04, 2025

Zynex CFO Daniel Moorhead sells $78,800 in common stock By Investing.com - Investing.com South Africa

Jan 04, 2025
pulisher
Jan 03, 2025

Insider Sell: Daniel Moorhead Sells 10,000 Shares of Zynex Inc (ZYXI) - GuruFocus.com

Jan 03, 2025
pulisher
Jan 03, 2025

Zynex CFO Daniel Moorhead sells $78,800 in common stock - Investing.com India

Jan 03, 2025
pulisher
Jan 03, 2025

Daniel J. Moorhead Sells 10,000 Shares of Zynex, Inc. (NASDAQ:ZYXI) Stock - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

CHIEF FINANCIAL OFFICER Moorhead Daniel J sold $78,800 worth of shares (10,000 units at $7.88), decreasing direct ownership by 28% to 26,299 units (SEC Form 4) - Quantisnow

Jan 03, 2025
pulisher
Jan 01, 2025

State Street Corp Sells 9,172 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Zynex Introduces New Products - GuruFocus.com

Jan 01, 2025
pulisher
Dec 30, 2024

ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial - MSN

Dec 30, 2024
pulisher
Dec 28, 2024

(ZYXI) Trading Signals - Stock Traders Daily

Dec 28, 2024
pulisher
Dec 19, 2024

Electrotherapy System Market Future Business Opportunities - openPR

Dec 19, 2024
pulisher
Dec 18, 2024

How to Take Advantage of moves in (ZYXI) - Stock Traders Daily

Dec 18, 2024
pulisher
Dec 18, 2024

Zynex partners with VA to expand pain management access By Investing.com - Investing.com Canada

Dec 18, 2024
pulisher
Dec 17, 2024

Zynex partners with VA to expand pain management access - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex's SWOT analysis: pain management firm's stock faces growth hurdles By Investing.com - Investing.com Canada

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex's SWOT analysis: pain management firm's stock faces growth hurdles - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex partners with VA to offer pain management solutions for veterans - Proactive Investors

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States – Company AnnouncementFT.com - Financial Times

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex partners with Veterans Affairs Medical Centers to deliver noninvasive pain relief solutions - Proactive financial news

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States - PR Newswire

Dec 17, 2024
pulisher
Dec 16, 2024

Zynex, Inc. Sets Second Quarter 2023 Earnings Call - GuruFocus.com

Dec 16, 2024
pulisher
Dec 14, 2024

Zynex CEO outlines plans for 2025 after revenue milestone – ICYMI - Proactive Investors Australia

Dec 14, 2024
pulisher
Dec 13, 2024

Zynex Announces Completion of Its Laser Pulse Oximetry Trial - The Eastern Progress Online

Dec 13, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters - The Malaysian Reserve

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex to Present at the HC Wainwright Global Investment Conference - The Eastern Progress Online

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits i - GuruFocus.com

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex study highlights precision of laser-based pulse oximeter in reducing racial bias - Proactive Investors UK

Dec 12, 2024
pulisher
Dec 11, 2024

Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates - MSN

Dec 11, 2024
pulisher
Dec 10, 2024

Zynex Sets Third Quarter 2024 Earnings Call - Longview News-Journal

Dec 10, 2024
pulisher
Dec 09, 2024

Zynex Inc. Achieves $200M Milestone and Sets Ambitious Goals for 2025 - Proactive Investors UK

Dec 09, 2024
pulisher
Dec 09, 2024

Non Invasive Pain Management Devices Market Overall Study - openPR

Dec 09, 2024
pulisher
Dec 07, 2024

Objective long/short (ZYXI) Report - Stock Traders Daily

Dec 07, 2024

Finanzdaten der Zynex Inc-Aktie (ZYXI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Zynex Inc-Aktie (ZYXI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
MOORHEAD DANIEL J
CHIEF FINANCIAL OFFICER
Dec 02 '24
Sale
8.08
10,000
80,800
35,190
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 14 '24
Sale
8.09
2,000
16,180
14,603,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 12 '24
Sale
9.24
2,000
18,480
14,607,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 07 '24
Sale
9.17
2,000
18,340
14,613,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 11 '24
Sale
9.09
2,000
18,180
14,609,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 08 '24
Sale
8.77
2,000
17,540
14,611,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 13 '24
Sale
8.37
2,000
16,740
14,605,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 06 '24
Sale
8.82
2,000
17,640
14,615,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 04 '24
Sale
8.67
2,000
17,340
14,619,350
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 05 '24
Sale
8.05
2,000
16,100
14,617,662
$2.26
price up icon 4.15%
medical_distribution YI
$0.4311
price up icon 1.32%
medical_distribution AHG
$1.49
price down icon 3.25%
medical_distribution OMI
$14.92
price up icon 2.33%
$30.95
price up icon 0.16%
Kapitalisierung:     |  Volumen (24h):